Concepedia

Yingchao Xie

YX

Statistics

Publications

3

Citations

82

H-Index

3

Active since

2022

Affiliations

Cell Technology (China)(Current)

Shantou University

Yue Bei People's Hospital

Southern Medical University

Third Affiliated Hospital of Southern Medical University

Yingchao Xie is an author at Cell Technology (China) specializing in aim2 inflammasome, inflammasome activation, and autophagy regulation.

ORCID

Publications per year

2022–2023

3

Publications

3

Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy

Huaji Jiang, Yingchao Xie, Jiansen Lu et al. · Autophagy · 2023 · 39 citations · Full text

, , +17

VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation

Z. Hu, Yingchao Xie, Jiansen Lu et al. · Science Advances · 2023 · 25 citations · Full text

, , +17

Inflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti- <i>Toxoplasma</i> Immunity

Zhiqiang Hu, Dan Wu, Jiansen Lu et al. · mBio · 2022 · 18 citations · Full text

, , +17

1–3 of 3